Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Danielle Bargo"'
Autor:
Pall Jonsson, Danielle Bargo, Seamus Kent, Philani Mpofu, Harlan Pittell, Brad Groves, Ivy Altomare, Amanda Copeland, Shrujal Baxi, Arun Sujenthiran, Blythe Adamson
Publikováno v:
BMJ Open, Vol 13, Iss 10 (2023)
Objectives Examine whether data from early access to medicines in the USA can be used to inform National Institute for Health and Care Excellence (NICE) health technology assessments (HTA) in oncology.Design Retrospective cohort study.Setting Oncolog
Externí odkaz:
https://doaj.org/article/42e89803cf02448a9253c50a3750dc27
Autor:
Danielle Bargo, Theo Tritton, Joseph C. Cappelleri, Marco DiBonaventura, Timothy W. Smith, Takanori Tsuchiya, Sean Gardiner, Irene Modesto, Tim Holbrook, Daniel Bluff, Taku Kobayashi
Publikováno v:
Inflammatory Intestinal Diseases, Vol 6, Iss 4, Pp 186-198 (2021)
Objective: The aim of the study was to improve understanding of adherence and persistence to biologics, and their association with health-care resource utilization (HCRU), in Japanese patients with moderate to severe ulcerative colitis (UC). Methods:
Externí odkaz:
https://doaj.org/article/7a6ded8a8a944227a1c15b6d75bcc505
Autor:
Alessandro Armuzzi, Miriam Tarallo, James Lucas, Daniel Bluff, Benjamin Hoskin, Danielle Bargo, Joseph C. Cappelleri, Leonardo Salese, Marco daCosta DiBonaventura
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Patients with ulcerative colitis (UC) experience periods of recurring and episodic clinical signs and symptoms. This study sought to establish the association between disease activity and health-related quality of life (HRQoL) and
Externí odkaz:
https://doaj.org/article/1b29afc5ddb74f37bb6596afb145435c
Autor:
Irina Proskorovsky, Agnes Benedict, Sylvie Negrier, Danielle Bargo, Rickard Sandin, Krishnan Ramaswamy, Jigar Desai, Joseph C. Cappelleri, James Larkin
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background In the absence of head-to-head trials comparing axitinib with cabozantinib or everolimus, the aim of this study was to conduct an indirect comparison of their relative efficacy in patients with metastatic renal cell carcinoma (mRC
Externí odkaz:
https://doaj.org/article/3fa403c1198d4ea3bd84bcca33a779db
Autor:
Joseph C Cappelleri, Matthew J Brookes, Natalie Bohm, John Waller, Irene Modesto, Marco D DiBonaventura, Ruth Mokgokong, Olivia Massey, Robert Wood, Danielle Bargo
Publikováno v:
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020)
Objective Ulcerative colitis (UC) is a lifelong, relapsing-remitting disease. Patients non-responsive to pharmacological treatment may require a colectomy. We estimated pre-colectomy and post-colectomy healthcare resource utilisation (HCRU) and costs
Externí odkaz:
https://doaj.org/article/c5d9c17e64254fdcb9025b0823da3aa2
Autor:
Alessandro Armuzzi, Marco daCosta DiBonaventura, Miriam Tarallo, James Lucas, Daniel Bluff, Benjamin Hoskin, Danielle Bargo, Joseph C Cappelleri, Daniel Quirk, Leonardo Salese
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227914 (2020)
OBJECTIVE:The aim of the present study is to examine how moderate-to-severe ulcerative colitis (UC) is currently managed in real-world clinical practice across the United States (US) and European Union Five (EU5; France, Germany, Italy, Spain, and th
Externí odkaz:
https://doaj.org/article/92dd4570321c481395ff3b2d04d21738
Autor:
Leonardo Salese, Danielle Bargo, Daniel Quirk, Millie D. Long, David Gruben, Timothy W. Smith, Marco DiBonaventura
Publikováno v:
Inflammatory Bowel Diseases
In this real-world analysis, patients with ulcerative colitis frequently required steroids up to a year after initiating immunosuppressant or biologic therapies, with high ulcerative colitis-related costs. This suggests an ongoing challenge in managi
Autor:
Millie D. Long, Russell D. Cohen, Timothy W. Smith, Marco DiBonaventura, David Gruben, Danielle Bargo, Leonardo Salese, Daniel Quirk
Publikováno v:
Digestive diseases (Basel, Switzerland). 40(5)
Background: Biologic therapies are often used in patients with ulcerative colitis (UC) who are nonresponsive to conventional treatments. However, nonresponse or loss of response to biologics often occurs, leading to dose escalation, combination thera
Autor:
Shuhag Ghosh, Shrujal S. Baxi, Xiaoliang Wang, Scott D. Ramsey, Blythe J.S. Adamson, Danielle Bargo, Neal J. Meropol
Publikováno v:
Journal of medical economics. 23(12)
Electronic health records (EHRs) can define real world patient populations with high levels of clinical specificity, potentially addressing some of the shortcomings of other types of real world data (RWD) when informing decisions about the comparativ
Autor:
Daniel Bluff, Danielle Bargo, M. Tarallo, Joseph C. Cappelleri, Leonardo Salese, James Lucas, Marco DiBonaventura, Alessandro Armuzzi, Benjamin Hoskin
Publikováno v:
BMC Gastroenterology
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-11 (2020)
Background Patients with ulcerative colitis (UC) experience periods of recurring and episodic clinical signs and symptoms. This study sought to establish the association between disease activity and health-related quality of life (HRQoL) and other pa